B-cell receptor specific for measles, mumps, and rubella virus epitopes (MMR-specific BCR)

B-cell receptors (BCRs) specific for measles, mumps, and rubella (MMR) virus epitopes are membrane-bound immunoglobulins that mediate the adaptive immune response to these pathogens. These receptors specifically recognize the Hemagglutinin (H) and Fusion (F) proteins of Measles virus, the Hemagglutinin-Neuraminidase (HN) and Fusion (F) proteins of Mumps virus, and the E1, E2, and Capsid proteins of Rubella virus [PMID: 30643320, 29167343, 25142593]. Binding of these viral antigens to the BCR triggers intracellular signaling pathways that lead to B-cell activation, proliferation, and differentiation into plasma cells and memory B cells [Janeway's Immunobiology]. This interaction is the fundamental mechanism by which live-attenuated MMR vaccines induce long-term protective immunity against infection [FDA]. In a clinical context, these BCRs are the targets of antigenic stimulation by vaccines and are monitored via the production of neutralizing antibodies in the serum. They are also of significant interest in the development of monoclonal antibodies for passive immunization and in the study of immune repertoire diversity following vaccination. While highly effective, the interaction between these receptors and vaccine antigens can occasionally lead to hypersensitivity reactions or require booster doses due to waning immunity over time.

Other names

Measles-Mumps-Rubella specific B-cell receptorsMMR-reactive BCRsAnti-MMR B-cell receptorsB-cell receptors for Measles H/F, Mumps HN/F, and Rubella E1/E2/C

Antigenic stimulation of B-cell receptors leads to clonal expansion and differentiation into antibody-secreting plasma cells and memory B cells.